The Fundsupermart All-Equity Fund Index March 2010 Update
Author : iFAST Research
Untitled Document
FEFI
Performance UPDate
The last month of the
fiscal year
2009-10 ended with a bang, with the FEFI gaining 7.05% in March 2010.
This gain
has provided much needed relief to the mutual fund investors who have
seen
negative performance for the past two months. As on 31 March 2010, the
FEFI closed
at 1868.57 points, registering a 7.05% gain for the month. In March the
SENSEX,
BSE 200, BSE 500 and CNX 500 indices gained by 6.7%, 6.2%, 6.2% and
4.5% respectively.
Thus, the performance of equity fund managers was much better this
month as
FEFI has outperformed the market indices.
Chart
1: FEFI Performance for 2010
Table 1:
FEFI Index
levels
FEFI
Year-to-date
(%)
Month-to-date
(%)
31
December 2009
1831.56
-
-
31
January
2010
1763.09
-
-3.7%
28
February
2010
1745.48
-4.7%
-1.0%
31
March 2010
1868.57
2.02%
7.05%
Table 2: Top 5 Equity
funds on
our platform in February
Four
of the five top performing equity
funds for March
are from the Pharmaceuticals and Diversified segments. The
Pharmaceuticals
indices have given good returns for the month of March, the BSE
Healthcare
index and the CNX Pharma index have risen by 8.45% and 8.75%
respectively. Except
for the Religare Banking fund, all the other funds have their MTD
returns
higher than the YTD returns. The Pharmaceuticals sector and
particularly the Reliance
Pharma fund have done very well so far and the Reliance Pharma Fund has
given
the highest YTD returns among all equity funds in India. The Reliance
Pharma Fund
has appeared in our monthly top 5 performing list, 4
times since October 2009.
Table 3: Bottom 5 Equity
funds on
our platform in February
Four funds from Birla Sun life mutual fund
figured in
the bottom 5 performing funds for March and most of the bottom 5 funds
belong
to the overseas category. The Rupee appreciated by 2.2% in March and
this can
be one of the causes for the low performance of global commodity funds.
The
Research Team is part of iFAST
Financial India Pvt Ltd
iFAST
and/or its content and research
team’s licensed representatives may own or have positions in
the
mutual funds of any of the Asset Management Company mentioned or
referred to in the article, and may from time to time add or dispose
of, or be materially interested in any such. This article is not to be
construed as an offer or solicitation for the subscription, purchase or
sale of any mutual fund. No investment decision should be taken without
first viewing a mutual fund's offer document/scheme additional
information/scheme information document. Any advice herein is made on a
general basis and does not take into account the specific investment
objectives of the specific person or group of persons. Investors should
seek for professional investment, tax, and legal advice before making
an investment or any other decision. Past performance and any forecast
is not necessarily indicative of the future or likely performance of
the mutual fund. The value of mutual funds and the income from them may
fall as well as rise. Opinions expressed herein are subject to change
without notice. Please read our disclaimer in the website.
